SJS Investment Consulting’s Charles River Laboratories CRL Stock Holding History

SJS Investment Consulting’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.4K	Sell	68 -37	-35%	-$6.59K	﹤0.01%	884
2026 Q1	$18.1K	Sell	105 -151	-59%	-$28K	﹤0.01%	693
2025 Q4	$51.1K	Sell	256 -53	-17%	-$9.61K	0.01%	348
2025 Q3	$48.3K	Buy	+309	New	+$49.1K	0.01%	336
2025 Q1	–	Sell	-3	Closed	-$554	–	1620
2024 Q4	$554	Sell	3 -6	-67%	-$1.16K	﹤0.01%	1206
2024 Q3	$1.77K	Buy	9 +1	+13%	+$208	﹤0.01%	845
2024 Q2	$1.65K	Hold	8	–	–	﹤0.01%	818
2024 Q1	$2.17K	Buy	8 +5	+167%	+$1.19K	﹤0.01%	708
2023 Q4	$710	Sell	3 -5	-63%	-$983	﹤0.01%	1100
2023 Q3	$1.57K	Buy	8 +3	+60%	+$616	﹤0.01%	740
2023 Q2	$1.05K	Sell	5 -1	-17%	-$199	﹤0.01%	886
2023 Q1	$1.21K	Hold	6	–	–	﹤0.01%	810
2022 Q4	$1.31K	Buy	6 +3	+100%	+$655	﹤0.01%	821
2022 Q3	$1K	Buy	+3	New	+$648	﹤0.01%	668
2022 Q1	$0	Buy	+1	New	+$308	﹤0.01%	823

Other funds holding CRL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

SJS Investment Consulting's CRL Position: Q2 2026 in Review

SJS Investment Consulting reduced its Charles River Laboratories (CRL) stake by 35% in Q2 2026, selling an estimated $6.59K and leaving 68 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #884.

SJS Investment Consulting first reported a position in CRL in Q1 2022 and has held it in 15 quarters since. The position peaked at $51.1K in Q4 2025. 287 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

SJS Investment Consulting held 68 shares of Charles River Laboratories worth $15.4K as of Q2 2026.
SJS Investment Consulting sold 37 Charles River Laboratories shares in Q2 2026, an estimated $6.59K.
Charles River Laboratories made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #884 holding.
SJS Investment Consulting first reported a position in Charles River Laboratories in Q1 2022 and has held it in 15 quarters since.
SJS Investment Consulting's Charles River Laboratories position peaked at $51.1K in Q4 2025.
287 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.